ClinConnect ClinConnect Logo
Search / Trial NCT00299975

A Dose Determination Study of Chinese Herbal Medicine for Functional Constipation

Launched by HONG KONG BAPTIST UNIVERSITY · Mar 6, 2006

Trial Information

Current as of August 02, 2025

Completed

Keywords

Randomized Controlled Trials Medicine, Chinese Traditional Medicine, Herbal Constipation

ClinConnect Summary

Functional constipation (FC) is a common complaint in clinical practice, with the estimated prevalence 14.3% in Hong Kong, as nearly affecting 1 million Hong Kong People in different extent. It is comparable with western population, which is 15% in North America. By the definition of Rome II criteria, FC comprises a group of functional disorders, which presents as persistent difficult, infrequent or seemingly incomplete defecation.

Constipation is often perceived to be benign, easily treated condition with short-term treatment being relatively straightforward. However, the fact is the mana...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of functional constipation with Rome II criteria
  • General stool type belongs to Type 1 to 4 according to Bristol Stool Form Scale
  • Complete spontaneous bowel movement≦2 movements per week
  • Exclusion Criteria:
  • Anti-diarrhoeal therapy
  • Drug-induced constipation
  • Medical history of important bowel pathology, such as inflammatory bowel disease, congenital or acquired megacolon / megarectum
  • Medical history of previous abdominal surgery
  • Taking chronic medications that contain any kind of herbs, mineral, or specific vitamin supplements
  • Medical history of carbohydrate malabsorption, hormonal disorder, cancer, diabetes mellitus, hypothyroidism, asthma, renal impairment and/or any other serious diseases
  • History of laxative abuse
  • History of allergy to Chinese herbal medicine
  • Psychiatric or addictive disorders
  • Pregnancy or breast-feeding
  • Any other serious diseases

About Hong Kong Baptist University

Hong Kong Baptist University (HKBU) is a leading academic institution dedicated to advancing research and innovation in health sciences. With a strong emphasis on interdisciplinary collaboration, HKBU conducts clinical trials that aim to enhance medical knowledge and improve patient outcomes. The university is committed to adhering to the highest ethical standards and regulatory requirements, ensuring the integrity and reliability of its research efforts. Through its robust research framework and skilled faculty, HKBU strives to contribute significantly to the fields of medicine and healthcare both locally and globally.

Locations

Hong Kong, , China

Patients applied

0 patients applied

Trial Officials

ZhaoXiang Bian, PhD

Principal Investigator

Hong Kong Baptist University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials